Morten Dræby Sørensen

Morten Dræby Sørensen has a diverse work experience spanning several organizations. Morten is currently a Principal Scientist at Symphogen, where they focus on antibody engineering, bispecific antibodies, and technology projects related to the development of therapeutic antibodies for oncology, inflammatory, and auto-immune diseases. Before joining Symphogen, Morten worked at Agilent Technologies as a Research Scientist, where they specialized in developing antibodies for cancer in vitro diagnostics. Morten was involved in antigen design, antibody production, and the development and improvement of technologies and methods. Prior to that, Morten worked as a Guest Researcher at CNIO, where they conducted research on cancer stem cells by utilizing phage display and cloning techniques. Morten also gained valuable experience as a Post Doc at Aarhus University, where they conducted research on biomarker identification and antibody selection using phage display for rare cells in heterogeneous populations. Early in their career, Morten worked as an Industrial PhD Student and Staff Scientist at FCMB ApS, focusing on various research projects. Morten also worked as a Research Assistant at Aarhus University, where they participated in the Sino-European Project on SARS Diagnostics and Antivirals, specifically in the generation and selection of antibodies targeting SARS coat proteins. Overall, Morten Dræby Sørensen's work experience showcases their expertise in antibody technology, phage display, cancer research, and technology development.

Morten Dræby Sørensen completed their education in the field of Molecular Biology. Morten obtained an MSc degree from Aarhus University in 2004. Later, they pursued their Doctor of Philosophy (Ph.D.) at the same university and completed it in 2011.